ABD.i
ABD.i offers an advanced AI-powered platform, ABD.i - Anomaly and Bias Detection Interface, designed to automatically detect qualitative anomalies and quantitative biases in cancer datasets. Their platform combines machine learning with domain expertise to ensure data accuracy, integrity, and equity for downstream analysis. Key features include qualitative anomaly detection, quantitative bias analysis, data equity optimization, automated preprocessing, comprehensive reporting, and HIPAA-compliant security. The business model appears to be tiered SaaS, with Free, Starter, and Pro plans offering increasing levels of functionality and support, ranging from basic anomaly detection to fairness-aware ML modeling and custom subgroup definitions. Their stated traction includes 99.7% anomaly detection accuracy, an 85% bias reduction rate, and over 1,000 patient records analyzed.
ABD.i
ABD.i offers an advanced AI-powered platform, ABD.i - Anomaly and Bias Detection Interface, designed to automatically detect qualitative anomalies and quantitative biases in cancer datasets. Their platform combines machine learning with domain expertise to ensure data accuracy, integrity, and equity for downstream analysis. Key features include qualitative anomaly detection, quantitative bias analysis, data equity optimization, automated preprocessing, comprehensive reporting, and HIPAA-compliant security. The business model appears to be tiered SaaS, with Free, Starter, and Pro plans offering increasing levels of functionality and support, ranging from basic anomaly detection to fairness-aware ML modeling and custom subgroup definitions. Their stated traction includes 99.7% anomaly detection accuracy, an 85% bias reduction rate, and over 1,000 patient records analyzed.